• LUK MENU
  • The company
    • Our approach
    • Our mission
    • Our history
    • Cookie and data policy
  • Our services
    • Market access opportunities
    • Application for reimbursement
    • Hospital product market access
    • Health economic models
    • Contract research
  • Our cases
    • Assessment of treatment for rare condition. Sweden
    • Market access for ultra-orphan disease
    • Global model QC and optimization
    • Reimbursement for orphan drugs
    • Market access in a genericized market
    • Hospital products
    • Market access IBS-C
    • Situation analysis
  • Our clients
  • Contact
MENU Wickstøm & Langkilde
  • The company
    • Our approach
    • Our mission
    • Our history
    • Cookie and data policy
  • Our services
    • Market access opportunities
    • Application for reimbursement
    • Hospital product market access
    • Health economic models
    • Contract research
  • Our cases
    • Assessment of treatment for rare condition. Sweden
    • Market access for ultra-orphan disease
    • Global model QC and optimization
    • Reimbursement for orphan drugs
    • Market access in a genericized market
    • Hospital products
    • Market access IBS-C
    • Situation analysis
  • Our clients
  • Contact

Our cases

We have collected a few of the many projects we have delivered over the years. They have been chosen because they represent cases that shows what we do, our approach and how we collaborate with our clients.

  • Our cases
  • Assessment of treatment for rare condition. Sweden Akcea Therapeutics Ltd
  • Market access for ultra-orphan disease EUSA Pharma
  • Global model QC and optimization Bristol-Myers Squibb
  • Reimbursement for orphan drugs Norgine
  • Market access in a genericized market Astellas Pharma
  • Hospital products
  • Market access IBS-C Almirall
  • Situation analysis Almirall

Our services

We provide a wide range of services you may need to secure market access in the Nordic markets. We have listed some of the services in the following. Please read more and do contact us for further information.

Wickstrøm & Langkilde ApS   Andkærvej 19d   DK-7100 Vejle   Reg. no: DK-315 88 154

Phone: +45 3514 1110   Mail: mail@wlpharma.com

LinkedIn

Follow us on Linkedin